Protective effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on copper-induced hydroxyl radical generation in the rat heart

Toxicology

Volumn 223, Issue 3, 2006, Pages 175-180

  Obata, Toshio ^a  

^a OHU UNIVERSITY   (Japan)

Author keywords

Copper ion; Fluvastatin; Hydroxyl radical; Low density lipoprotein (LDL); Microdialysis

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; COPPER; FLUINDOSTATIN; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RINGER SOLUTION; SALICYLATE SODIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSATE; DOSE RESPONSE; DRUG EFFECT; HEART; HEART MUSCLE; HEART PROTECTION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; CARDIOTONIC AGENTS; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; FATTY ACIDS, MONOUNSATURATED; HYDROXYBENZOIC ACIDS; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; MICRODIALYSIS; MYOCARDIUM; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33744527506     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.006     Document Type: Article

References (28)

1. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98 (1993) 1-9
2. Bandoh T., Sato E.F., Mitani H., Nakashima A., Hoshi K., and Inoue M. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Biol. Pharm. Bull. 26 (2003) 818-822
3. Belinky P.A., Aviram M., Mahmood S., and Vaya J. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic. Biol. Med. 24 (1998) 1419-1429
4. Benveniste H. Brain microdialysis. J. Neurochem. 52 (1989) 1667-1679
5. Chiueh C.C., Wu R.-M., Mohanakumar K.P., Sternberger L.M., Krishna G., Obata T., and Murphy D.L. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. N.Y. Acad. Sci. 738 (1994) 25-36
6. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) 11127-11132
7. Gabbianelli R., Santroni A.M., Fedeli D., Kantar A., and Falcioni G. Antioxidant activities of different hemoglobin derivatives. Biochem. Biophys. Res. Commun. 242 (1998) 560-564
8. Halliwell B., Kaur H., and Ingleman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10 (1991) 439-441
9. Hamilton J.A., Jessup W., Brown A.J., and Whitty G. Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL. Biochem. J. 355 (2001) 207-214
10. Hayashi K., Kurokawa J., Nomura S., Kuga Y., Ohkura Y., and Kajiyama G. Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells. Biochim. Biophys. Acta 1167 (1993) 223-225
11. Hussein O., Schlezinger S., Rosenblat M., Keidar S., and Aviram M. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis 128 (1997) 11-18
12. Kurokawa J., Hayashi K., Toyota Y., Shingu T., Shiomi M., and Kajiyama G. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits. Biochim. Biophys. Acta 1259 (1995) 99-104
13. Leonhardt W., Kurktschiev T., Meissner D., Lattke P., Abletshauser C., Weidinger G., Jaross W., and Hanefeld M. Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals. Eur. J. Clin. Pharmacol. 53 (1997) 65-69
14. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci. 71 (2002) 2083-2103
15. +-induced hydroxyl radical generation: a review. J. Neural Transm. [GenSect], in press.
16. Obata T., Ebihara A., and Yamanaka Y. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart. Biochim. Biophys. Acta 1536 (2001) 55-63
17. Obata T., Hosokawa H., and Yamanaka Y. In vivo monitoring of norepinephrine and {radical dot}OH generation on myocardial ischemic injury by dialysis technique. Am. J. Physiol. 266 (1994) H903-H908
18. Pietri S., Maurelli E., Drieu K., and Culcasi M. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J. Mol. Cell Cardiol. 29 (1997) 733-742
19. Ross R. The pathogenesis or atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
20. Schnitzer E., Pinchuk I., Bor A., Fainaru M., and Lichtenberg D. The effect of albumin on copper-induced LDL oxidation. Biochem. Biophys. Acta 1344 (1997) 300-311
21. 2+. Arch. Biochem. Biophys. 347 (1997) 45-52
22. 2+, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production. A comparison to other extracts or compounds. Free Radic. Res. 37 (2003) 573-584
23. Slezak J., Tribulova N., Pristacova J., Uhrik B., Thomas T., Khaper N., Kaul N., and Singal P.K. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am. J. Pathol. 147 (1995) 772-781
24. Steinberg D., Parthasarathy S., Carew T.E., Khoo I.C., and Witztum J.L. Modification of low-density lipoprotein that increase its atherogenecity. N. Engl. J. Med. 320 (1989) 915-924
25. Sugawa M., Ikeda S., Kushima Y., Takashima Y., and Cynshi O. Oxidized low density lipoprotein caused CNS neuron cell death. Brain Res. 761 (1997) 165-172
26. Vaage J., Antonelli M., Bufi M., Irtun O., DeBlasi R.A., Corbucci G.G., Gasparetto A., and Semb A.G. Exogenous reactive oxygen species deplete the isolated rat heart of antioxidants. Free Radic. Biol. Med. 22 (1997) 85-92
27. Wassmann S., Faul A., Hennen B., Scheller B., Bohm M., and Nickenig G. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ. Res. 93 (2003) 98-103
28. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88 (1991) 1785-1792